A 10x earning multiple is more than twice the average for the biotech group. Biotech already has one of the highest forward multiples for an industry. My suggesting using a multiple that is 20% higher than the biotech average is countered by your insinuation that I'm being pessimistic. Take a step back and think about that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.